Business Medical Dialogues
    • facebook
    • twitter
    Login Register
    • facebook
    • twitter
    Login Register
    • Medical Dialogues
    • Speciality Dialogues
    • Education Dialogues
    • Medical Jobs
    • Medical Matrimony
    • MD Brand Connect
    Business Medical Dialogues
    • News
        • Financial Results
        • Hospitals & Diagnostics
        • IT / Health Venture
        • Implants / Devices
        • Insurance
        • Key Movement
        • Pharmaceuticals
        • Policy
        • Technology
        • pharma-news
    • blog
    LoginRegister
    Business Medical Dialogues
    LoginRegister
    • Home
    • News
      • Financial Results
      • Hospitals & Diagnostics
      • IT / Health Venture
      • Implants / Devices
      • Insurance
      • Key Movement
      • Pharmaceuticals
      • Policy
      • Technology
      • pharma-news
    • blog
    • Home
    • Latest News

    Latest News - Page 224

    Wrong Labelling: Intas Pharma US arm recalls over 46,000 bottles of diuretic drug

    Wrong Labelling: Intas Pharma US arm recalls over 46,000 bottles of diuretic drug

    Medical Dialogues Bureau24 Sept 2018 12:38 PM IST
    Accord Healthcare recall is based on "Labelling: label mix-up: customer complaint that a sealed bottle labelled as Hydrochlorothiazide tablets USP...
    Bayer says Monsanto India integration to complete in one year

    Bayer says Monsanto India integration to complete in one year

    Medical Dialogues Bureau24 Sept 2018 9:00 AM IST
    Bayer completed the USD 63 billion mega-deal to acquire US-based Monsanto to create the world's biggest agrochemical and seed company. New Delhi: It...
    CDSCO launches blood products module under SUGAM

    CDSCO launches blood products module under SUGAM

    Medical Dialogues Bureau23 Sept 2018 10:15 AM IST
    New Delhi: Through a recent notice Ministry of Health & Family Welfare, Director General of Health Services, Central Drugs Standard Control...
    Inventia Healthcare files Rs 450-cr IPO papers with SEBI

    Inventia Healthcare files Rs 450-cr IPO papers with SEBI

    Medical Dialogues Bureau23 Sept 2018 10:00 AM IST
    NEW DELHI: Inventia Healthcare has filed draft papers with capital markets regulator SEBI to raise an estimated Rs 450 crore through an initial public...
    Swiss medtech firm Implantica plans stock market listing

    Swiss medtech firm Implantica plans stock market listing

    Medical Dialogues Bureau23 Sept 2018 9:33 AM IST
    Implantica regularly reviews available financing alternatives to finance the commercialization of its first implant, RefluxStop, and to accelerate the...
    Mylan, Biocon bag Positive CHMP opinion for pegfilgrastim biosimilar, Fulphila

    Mylan, Biocon bag Positive CHMP opinion for pegfilgrastim biosimilar, Fulphila

    Medical Dialogues Bureau23 Sept 2018 9:00 AM IST
    Biocon and pharma firm Mylan said CHMP has a positive opinion recommending approval for their pegfilgrastim biosimilar, Fulphila.New Delhi:...
    Sun Pharma gets Australia TGA nod for ILUMYA to treat plaque psoriasis

    Sun Pharma gets Australia TGA nod for ILUMYA to treat plaque psoriasis

    Medical Dialogues Bureau22 Sept 2018 12:38 PM IST
    ILUMYA used for the treatment of adults with plaque psoriasis. The program is designed to supplement the support offered by doctors in their practice...
    Aspen Pharma suffers week of woe as valuation tumbles by $3 billion

    Aspen Pharma suffers week of woe as valuation tumbles by $3 billion

    Medical Dialogues Bureau22 Sept 2018 9:42 AM IST
    The Aspen Pharma share price has tumbled more than 35 per cent since it posted full-year results and announced the baby milk disposal to French dairy...
    Takeda gets European panel nod for Alunbrig to treat lung cancer

    Takeda gets European panel nod for Alunbrig to treat lung cancer

    Medical Dialogues Bureau22 Sept 2018 9:33 AM IST
    The European Medicines Agency's Committee for Medicinal Products for Human Use recommended granting Japan-based Takeda's Alunbrig, or brigatinib, a...
    Soon Indian Standard for medical devices, says VK Paul

    Soon Indian Standard for medical devices, says VK Paul

    Medical Dialogues Bureau21 Sept 2018 1:37 PM IST
    New Delhi: A range of medical devices, old or new, will soon have an 'Indian standard' and nearly 1,000 products are presently being benchmarked, a...
    Australian Competition and Consumer Commission clears Arrow ,Apotex merger: Strides

    Australian Competition and Consumer Commission clears Arrow ,Apotex merger: Strides

    Medical Dialogues Bureau21 Sept 2018 1:15 PM IST
    Strides Pharma Science Thursday said the Australian Competition and Consumer Commission (ACCC) has decided not to oppose the merger of generic pharma...
    ICRA upgrades long-term credit rating of Fortis Healthcare

    ICRA upgrades long-term credit rating of Fortis Healthcare

    Medical Dialogues Bureau21 Sept 2018 1:01 PM IST
    New Delhi: Fortis Healthcare Thursday said rating agency ICRA has upgraded its long-term credit rating as it has repaid the overdue debt obligations...
    PrevNext

    Popular Stories

    FDC Ban: Supreme Court Relief to Saridon, Piriton and Dart

    FDC Ban: Supreme Court Relief to Saridon, Piriton and Dart

    Ayurvedic Medicines for Blood Sugar, Diet containing Metformin Hydrochloride: Ayurveda Firm Booked

    Ayurvedic Medicines for Blood Sugar, Diet containing Metformin Hydrochloride: Ayurveda Firm Booked

    CDSCO bans OTC sale of topical medications containing hydroquinone from April 1, 2019

    CDSCO bans OTC sale of topical medications containing hydroquinone from April 1, 2019

    Rising prices of hydroxychloroquine raw material forces small scale pharmas in Haridwar to stop production

    Rising prices of hydroxychloroquine raw material forces small scale pharmas in Haridwar to stop...

    Owners of BLK Hospital, Nanavati Hospital now own 49.7 percent stake in Max Healthcare

    Owners of BLK Hospital, Nanavati Hospital now own 49.7 percent stake in Max Healthcare

    Hydroxychloroquine not approved as anti-malarial drug in India, says Ipca Laboratories Joint MD

    Hydroxychloroquine not approved as anti-malarial drug in India, says Ipca Laboratories Joint MD

    Shipment of  antimalarial drug to US is likely to start next week: Indian Pharmaceutical Alliance

    Shipment of antimalarial drug to US is likely to start next week: Indian Pharmaceutical Alliance

    Union Pharma Secretary Holds video conference with Pharma manufacturers and associations, takes feedback

    Union Pharma Secretary Holds video conference with Pharma manufacturers and associations, takes...

    View All

    • Email: info@medicaldialogues.in
    • Phone: 011 - 4372 0751

    Website Last Updated On : 13 Oct 2022 5:14 AM GMT
    Company
    • About Us
    • Contact Us
    • Our Team
    • Reach our Editor
    • Feedback
    • Submit Article
    Ads & Legal
    • Advertise
    • Advertise Policy
    • Terms and Conditions
    • Privacy Policy
    • Editorial Policy
    • Comments Policy
    • Disclamier
    Medical Dialogues is health news portal designed to update medical and healthcare professionals but does not limit/block other interested parties from accessing our general health content. The health content on Medical Dialogues and its subdomains is created and/or edited by our expert team, that includes doctors, healthcare researchers and scientific writers, who review all medical information to keep them in line with the latest evidence-based medical information and accepted health guidelines by established medical organisations of the world.

    Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription.Use of this site is subject to our terms of use, privacy policy, advertisement policy. You can check out disclaimers here. © 2025 Minerva Medical Treatment Pvt Ltd

    © 2025 - Medical Dialogues. All Rights Reserved.
    Powered By: Hocalwire
    X
    We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok